Piceatannol and its metabolite, isorhapontigenin, Induce SIRT1 expression in THP-1 human monocytic cell line

Nutrients

Volumn 6, Issue 11, 2014, Pages 4794-4804

  Kawakami, Shinpei ^a   Kinoshita, Yosuke ^a   Maruki Uchida, Hiroko ^a   Yanae, Koji ^a   Sai, Masahiko ^a   Ito, Tatsuhiko ^a  

^a Morinaga and Company Limited   (Japan)

Author keywords

Isorhapontigenin; Piceatannol; Resveratrol; Sirtuin 1; THP 1

Indexed keywords

ALCOHOL; DIMETHYL SULFOXIDE; DRUG METABOLITE; ISORHAPONTIGENIN; MESSENGER RNA; PASSION FRUIT EXTRACT; PICEATANNOL; PLANT EXTRACT; RESVERATROL; SIRTUIN 1; UNCLASSIFIED DRUG; 3,3',4,5'-TETRAHYDROXYSTILBENE; SIRT1 PROTEIN, HUMAN; STILBENE DERIVATIVE;

ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PLANT SEED; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; THP 1 HUMAN MONOCYTIC CELL LINE; UPREGULATION; WESTERN BLOTTING; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM; MONOCYTE; PASSIFLORA;

CELL LINE; HUMANS; MONOCYTES; PASSIFLORA; PLANT EXTRACTS; RNA, MESSENGER; SEEDS; SIRTUIN 1; STILBENES; UP-REGULATION;

EID: 84908284803     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6114794     Document Type: Article

References (28)

1. Piotrowska, H.; Kucinska, M.; Murias, M. Biological activity of piceatannol: Leaving the shadow of resveratrol. Mutat. Res. 2012, 750, 60-82.
2. Kwon, J.Y.; Seo, S.G.; Heo, Y.S.; Yue, S.; Cheng, J.X.; Lee, K.W.; Kim, K.H. Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation. J. Biol. Chem. 2012, 287, 11566-11578.
3. Matsui, Y.; Sugiyama, K.; Kamei, M.; Takahashi, T.; Suzuki, T.; Katagata, Y.; Ito, T. Extract of passion fruit (Passiflora edulis) seed containing high amounts of piceatannol inhibits melanogenesis and promotes collagen synthesis. J. Agric. Food Chem. 2010, 58, 11112-11118.
4. Sano, S.; Sugiyama, K.; Ito, T.; Katano, Y.; Ishihata, A. Identification of the strong vasorelaxing substance scirpusin b, a dimer of piceatannol, from passion fruit (Passiflora edulis) seeds. J. Agric. Food Chem. 2011, 59, 6209-6213.
5. Kinoshita, Y.; Kawakami, S.; Yanae, K.; Sano, S.; Uchida, H.; Inagaki, H.; Ito, T. Effect of long-term piceatannol treatment on enos levels in cultured endothelial cells. Biochem. Biophys. Res. Commun. 2013, 430, 1164-1168.
6. Maruki-Uchida, H.; Kurita, I.; Sugiyama, K.; Sai, M.; Maeda, K.; Ito, T. The protective effects of piceatannol from passion fruit (Passiflora edulis) seeds in UVB-irradiated keratinocytes. Biol. Pharm. Bull. 2013, 36, 845-849.
7. Setoguchi, Y.; Oritani, Y.; Ito, R.; Inagaki, H.; Maruki-Uchida, H.; Ichiyanagi, T.; Ito, T. Absorption and metabolism of piceatannol in rats. J. Agric. Food. Chem. 2014, 62, 2541-2548.
8. Eseberri, I.; Lasa, A.; Churruca, I.; Portillo, M.P. Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytes. PLoS One 2013, 8, e63918.
9. Hoshino, J.; Park, E.J.; Kondratyuk, T.P.; Marler, L.; Pezzuto, J.M.; van Breemen, R.B.; Mo, S.; Li, Y.; Cushman, M. Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J. Med. Chem. 2010, 53, 5033-5043.
10. Guarente, L.; Picard, F. Calorie restriction-The SIR2 connection. Cell 2005, 120, 473-482.
11. Lavu, S.; Boss, O.; Elliott, P.J.; Lambert, P.D. Sirtuins-Novel therapeutic targets to treat age-associated diseases. Nat. Rev. Drug Discov. 2008, 7, 841-853.
12. de Kreutzenberg, S.V.; Ceolotto, G.; Papparella, I.; Bortoluzzi, A.; Semplicini, A.; Dalla Man, C.; Cobelli, C.; Fadini, G.P.; Avogaro, A. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: Potential biochemical mechanisms. Diabetes 2010, 59, 1006-1015.
13. Breitenstein, A.; Wyss, C.A.; Spescha, R.D.; Franzeck, F.C.; Hof, D.; Riwanto, M.; Hasun, M.; Akhmedov, A.; von Eckardstein, A.; Maier, W.; et al. Peripheral blood monocyte Sirt1 expression is reduced in patients with coronary artery disease. PLoS One 2013, 8, e53106.
14. Chung, S.; Yao, H.; Caito, S.; Hwang, J.W.; Arunachalam, G.; Rahman, I. Regulation of SIRT1 in cellular functions: Role of polyphenols. Arch. Biochem. Biophys. 2010, 501, 79-90.
15. Baur, J.A. Biochemical effects of sirt1 activators. Biochim. Biophys. Acta 2010, 1804, 1626-1634.
16. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 2006, 127, 1109-1122.
17. Wang, G.L.; Fu, Y.C.; Xu, W.C.; Feng, Y.Q.; Fang, S.R.; Zhou, X.H. Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via SIRT1-foxo1 signaling pathway. Biochem. Biophys. Res. Commun. 2009, 380, 644-649.
18. Andrade, J.M.; Frade, A.C.; Guimaraes, J.B.; Freitas, K.M.; Lopes, M.T.; Guimaraes, A.L.; de Paula, A.M.; Coimbra, C.C.; Santos, S.H. Resveratrol increases brown adipose tissue thermogenesis markers by increasing SIRT1 and energy expenditure and decreasing fat accumulation in adipose tissue of mice fed a standard diet. Eur. J. Nutr. 2014, 53, 1503-1510.
19. Yun, J.M.; Chien, A.; Jialal, I.; Devaraj, S. Resveratrol up-regulates sirt1 and inhibits cellular oxidative stress in the diabetic milieu: Mechanistic insights. J. Nutr. Biochem. 2012, 23, 699-705.
20. Kahyo, T.; Ichikawa, S.; Hatanaka, T.; Yamada, M.K.; Setou, M. A novel chalcone polyphenol inhibits the deacetylase activity of sirt1 and cell growth in hek293t cells. J. Pharmacol. Sci. 2008, 108, 364-371.
21. Gualdoni, G.A.; Kovarik, J.J.; Hofer, J.; Dose, F.; Pignitter, M.; Doberer, D.; Steinberger, P.; Somoza, V.; Wolzt, M.; Zlabinger, G.J. Resveratrol enhances TNF-alpha production in human monocytes upon bacterial stimulation. Biochim. Biophys. Acta 2014, 1840, 95-105.
22. Kuhnle, G.; Spencer, J.P.; Chowrimootoo, G.; Schroeter, H.; Debnam, E.S.; Srai, S.K.; Rice-Evans, C.; Hahn, U. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem. Biophys. Res. Commun. 2000, 272, 212-217.
23. Wenzel, E.; Soldo, T.; Erbersdobler, H.; Somoza, V. Bioactivity and metabolism of trans-resveratrol orally administered to wistar rats. Mol. Nutr. Food Res. 2005, 49, 482-494.
24. Xiong, S.; Salazar, G.; Patrushev, N.; Alexander, R.W. FoxO1 mediates an autofeedback loop regulating SIRT1 expression. J. Biol. Chem. 2011, 286, 5289-5299.
25. La Porte, C.; Voduc, N.; Zhang, G.; Seguin, I.; Tardiff, D.; Singhal, N.; Cameron, D.W. Steady-state pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin. Pharmacokinet. 2010, 49, 449-454.
26. Takeda-Watanabe, A.; Kitada, M.; Kanasaki, K.; Koya, D. SIRT1 inactivation induces inflammation through the dysregulation of autophagy in human THP-1 cells. Biochem. Biophys. Res. Commun. 2012, 427, 191-196.
27. Kitada, M.; Kume, S.; Takeda-Watanabe, A.; Tsuda, S.; Kanasaki, K.; Koya, D. Calorie restriction in overweight males ameliorates obesity-related metabolic alterations and cellular adaptations through anti-aging effects, possibly including ampk and sirt1 activation. Biochim. Biophys. Acta 2013, 1830, 4820-4827.
28. Pfluger, P.T.; Herranz, D.; Velasco-Miguel, S.; Serrano, M.; Tschop, M.H. SIRT1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. USA 2008, 105, 9793-9798.